TPC
AMWL icon

Takeda Pharmaceutical Company’s American Well AMWL Stock Holding History

Takeda Pharmaceutical Company’s Portfolio AMWL Stock Details AMWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$478K Hold
77,733
– – 2.92% 6
2025
Q2 		$691K Hold
77,733
– – 3.53% 4
2025
Q1 		$613K Hold
77,733
– – 3.78% 5
2024
Q4 		$564K Hold
77,733
– – 2.12% 6
2024
Q3 		$737K Hold
77,733
– – 1.94% 7
2024
Q2 		$505K Hold
77,733
– – 0.22% 11
2024
Q1 		$1.26M Hold
77,733
– – 0.44% 11
2023
Q4 		$2.32M Buy
+77,733
New +$1.91M 0.71% 7

Other funds holding AMWL

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RPA
Rock Point Advisors Burlington, Vermont $370M AUM 23.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Takeda Pharmaceutical Company's AMWL Position: Q3 2025 in Review

Takeda Pharmaceutical Company held its American Well (AMWL) position steady in Q3 2025 at 77,733 shares worth $478K. The position accounts for 2.92% of the portfolio, ranked #6.

Takeda Pharmaceutical Company first reported a position in AMWL in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.32M in Q4 2023. 59 funds tracked by Wall St. Rank hold AMWL as of Q3 2025.

  • Takeda Pharmaceutical Company held 77,733 shares of American Well worth $478K as of Q3 2025.
  • Takeda Pharmaceutical Company left its American Well share count unchanged in Q3 2025.
  • American Well made up 2.92% of Takeda Pharmaceutical Company's portfolio in Q3 2025, its #6 holding.
  • Takeda Pharmaceutical Company first reported a position in American Well in Q4 2023 and has held it in 8 quarters since.
  • Takeda Pharmaceutical Company's American Well position peaked at $2.32M in Q4 2023.
  • 59 funds tracked by Wall St. Rank held American Well as of Q3 2025.

Based on Takeda Pharmaceutical Company's 13F filing for Q3 2025, filed 13 Nov 2025.